Dear Doctor Letter (Rote-Hand-Brief) on Samsca® (tolvaptan): Risk of too rapid rise of serum sodium
2012.03.27
Active substance: tolvaptan
The pharmaceutical manufacturer issues information on the risk of a too rapid rise of serum sodium levels due to the use of Samsca® (tolvaptan) and on how this risk can be reduced.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN